Figure 3c,d depicts the disease-specific survival of obese colorectal cancer patients according to predicted expression of ARID3B in the discovery (Figure 3c, HR (hazard ratio) = 0.66; p = 0.005 for an expression higher vs. lower than the median) and validation datasets (Figure 3d, HR = 0.74; p = 0.04). Here, ARID3B is linked to colorectal cancer.